Leadership Overview
Rho has 7 executives leading key functions including strategy, operations, finance, technology, medical affairs, and corporate development.
Driven by a commitment to advancing medical breakthroughs, Rho provides comprehensive clinical research services across the entire drug development process, impacting global health outcomes.
Driven by a commitment to advancing medical breakthroughs, Rho provides comprehensive clinical research services across the entire drug development process, impacting global health outcomes.
Leadership Roles at Rho
Lawrence Morentz - Chief Executive Officer
Lawrence Morentz, the Chief Executive Officer at Rho, directs the overarching corporate strategy and operational framework. Morentz guides the organization's expansion within the contract research organization (CRO) sector, ensuring alignment with market demands for comprehensive drug development services. This leadership involves fostering innovation in clinical trial management and maintaining Rho's position as a key player in the pharmaceutical research landscape. The Chief Executive Officer's purview extends to cultivating strategic partnerships and driving the company's long-term vision. By overseeing all facets of the business, Lawrence Morentz ensures the efficient execution of research protocols and the delivery of high-quality data to clients, ultimately accelerating the path to new therapies. The Chief Executive Officer's role is central to Rho's mission of advancing medical science through rigorous research.
Francis Wall - Chief Financial Officer
Francis Wall, the Chief Financial Officer at Rho, oversees all financial planning, management, and reporting activities. Wall directs the fiscal strategy, ensuring robust financial health and sustainable growth for the contract research organization. This includes managing capital allocation, optimizing investment strategies, and maintaining strong relationships with financial institutions. The Chief Financial Officer's role is critical in providing financial insights that support strategic decision-making across the company. By meticulously managing financial operations, Francis Wall safeguards the company's assets and enhances shareholder value. The Chief Financial Officer's expertise is essential for navigating the complex financial landscape of the pharmaceutical services industry and supporting Rho's ongoing research initiatives.
Stas Johnson-Chyzhykov - Chief Operating Officer
Stas Johnson-Chyzhykov, the Chief Operating Officer at Rho, manages the day-to-day operational execution of clinical research services. Johnson-Chyzhykov oversees the integration of diverse research functions, ensuring seamless project delivery from early-phase trials to late-stage development. This involves optimizing resource allocation and implementing best practices across all operational departments. The Chief Operating Officer's responsibilities include enhancing operational efficiency and maintaining the highest standards of quality and compliance in clinical research activities. By focusing on process improvement, Stas Johnson-Chyzhykov drives the effective deployment of Rho's service offerings. The Chief Operating Officer's strategic oversight ensures that the company consistently meets client objectives and regulatory requirements, solidifying Rho's reputation for reliable research support.
Deborah Johnson - President
Deborah Johnson, the President at Rho, spearheads key strategic initiatives and operational oversight, contributing to the company's sustained growth and market leadership. Johnson directs cross-functional teams to enhance service delivery and client engagement within the contract research sector. This involves fostering a culture of excellence and innovation across all departments. The President's role is instrumental in shaping Rho's corporate direction and ensuring the effective implementation of its business objectives. By driving operational improvements and strategic partnerships, Deborah Johnson reinforces Rho's commitment to providing comprehensive clinical research solutions. The President's leadership ensures the company consistently meets and exceeds client expectations in the dynamic field of drug development.
Mary Helms - President & Co-Founder
Mary Helms, the President & Co-Founder at Rho, provides foundational leadership and strategic vision, guiding the company's long-term trajectory and market positioning. Helms contributes extensive experience in clinical research to shape the organization's core services and operational philosophy. This involves fostering innovation and ensuring the highest standards of quality in all research endeavors. The President & Co-Founder's role is critical in maintaining Rho's commitment to scientific integrity and client success. By leveraging deep industry knowledge, Mary Helms drives the company's mission to accelerate drug development and improve patient outcomes. The President & Co-Founder's enduring influence ensures Rho remains a trusted partner in advancing medical science.
Biljana Djordjevic - Technology Chief of Staff
Biljana Djordjevic, the Technology Chief of Staff at Rho, drives the strategic alignment and execution of technology initiatives across the organization. Djordjevic collaborates with leadership to define and implement technology roadmaps that support Rho's clinical research services and operational goals. This involves overseeing the integration of innovative technological solutions to enhance data management, trial efficiency, and client communication. The Technology Chief of Staff's focus is on leveraging technology to streamline processes and foster a data-driven research environment. By ensuring technological advancements align with business objectives, Biljana Djordjevic plays a pivotal role in Rho's digital transformation and its ability to deliver cutting-edge research services. The Technology Chief of Staff's leadership ensures Rho remains at the forefront of technological application in clinical research.
Andrew Feigin - Chief Medical Officer
Andrew Feigin, the Chief Medical Officer at Rho, provides critical medical and scientific leadership for the company's clinical research services. Feigin guides the strategic direction of clinical development programs, ensuring scientific rigor and ethical conduct throughout the drug development process. This leadership involves overseeing the medical aspects of clinical trials, interpreting complex data, and advising clients on therapeutic strategies. The Chief Medical Officer's expertise is vital in translating scientific insights into actionable research plans. By championing medical excellence, Andrew Feigin contributes significantly to Rho's mission of advancing healthcare solutions. The Chief Medical Officer's role ensures that all research conducted adheres to the highest medical and scientific standards, supporting the successful progression of novel treatments.
Explore Leadership Teams in Business Services
Brookings Institution operates as a nonprofit public policy research organization dedicated to generating actionable insights that address complex societal challenges. The organization conducts rigorous, in-depth research across multiple domains, translating academic inquiry into practical solutions for policymakers, business leaders, and civic stakeholders. Through its multidisciplinary approach, Brookings examines pressing issues spanning economics, governance, international affairs, and social policy, producing analysis that informs decision-making at local, national, and global scales. The institution's research methodology combines empirical investigation with expert analysis, drawing on scholars and practitioners who bring deep subject matter expertise to their work. Brookings produces comprehensive reports, policy briefs, and thought leadership that synthesize complex data into accessible recommendations. The organization's work spans both domestic policy challenges and international relations, reflecting the interconnected nature of modern governance and economic systems. Brookings maintains a commitment to nonpartisan analysis, striving to present evidence-based perspectives that transcend ideological boundaries. The institution engages with government officials, corporate executives, nonprofit leaders, and the broader public through publications, conferences, and direct consultation.
Company Leadership JS
SC
AM
ES
Altasciences Inc is a contract research organization. It provides preclinical and clinical services, manufacturing and analytical services, bioanalytical, and CRO services. The company was formed in 1992 and is based in Laval, Canada.
Company Leadership CP
CS
GM
Founded in 1949, Sandia National Laboratories, managed and operated by the National Technology and Engineering Solutions of Sandia, is one of three National Nuclear Security Administration research and development laboratories in the United States. They are headquartered in Albuquerque, New Mexico.
Company Leadership JP
DH
Boditech Med is a global leader in point-of-care testing with a decades-long track record of improving health and quality of life through innovative in-vitro diagnostic solutions. Since its launch in 1998, Boditech has developed 85 biomarkers, which support capillary blood, venous blood, and plasma testing, to meet customers' evolving needs. Listed as a public company on the KOSDAQ, Boditech's products aid patients and clinicians in 120 countries.
Company Leadership EC
EC
YC
Frequently Asked Questions Regarding Rho Top Executives and Leadership Team
